Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure
NCT01298258 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2011-02-17
Summary
The investigators hypothesize that the different components of arterial load are coupled with different components of LV function. The regional ventriculo-arterial couplings may be important in the pathogenesis of heart failure and ventricular remodeling, and in the prediction of future cardiovascular events.
Conditions
Interventions
- DRUG
-
Aliskiren
Aliskiren 150mg
Sponsors & Collaborators
-
National Taiwan University Hospital
collaborator OTHER -
Taipei Veterans General Hospital, Taiwan
lead OTHER_GOV
Principal Investigators
-
Chen-Huan chen, M.D. · Taipei Veterans General Hospital, Taiwan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
RAAS Inhibitor Drugs in Dialysis Patients
NCT01635387 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Effects of Intrarenal Nesiritide
NCT00270829 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients
NCT01503671 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
NCT02546583 ·Status: COMPLETED ·Phase: PHASE1
-
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
NCT06630923 ·Status: RECRUITING ·Phase: PHASE3
-
Aldosterone and Vascular Disease in Diabetes Mellitus
NCT00214825 ·Status: COMPLETED ·Phase: NA
-
Aliskiren and Renin Inhibition in Diastolic Heart Failure
NCT00773084 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
NCT00613964 ·Status: TERMINATED ·Phase: PHASE4
-
Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
NCT00972569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyperuricemia and Left Ventricular Diastolic Function
NCT03495999 ·Status: TERMINATED
-
Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human
NCT01069042 ·Status: UNKNOWN ·Phase: PHASE4
-
Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart
NCT01944384 ·Status: COMPLETED ·Phase: PHASE4
-
Role of ARNi in Ventricular Remodeling in Hypertensive LVH
NCT03553810 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Renin Angiotensin Aldosterone System Genetic Polymorphism on the Pharmacological Effect of Mineralocorticoid Receptor Antagonists in Patients With Myocardial Infarction
NCT05873400 ·Status: UNKNOWN
-
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
NCT05688579 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
NCT02497300 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Renin Inhibition and the Kidney
NCT01217736 ·Status: COMPLETED ·Phase: PHASE1
-
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
NCT00119691 ·Status: COMPLETED ·Phase: PHASE2
-
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
NCT01129557 ·Status: TERMINATED ·Phase: PHASE4
-
Aldosterone Antagonism in Diastolic Heart Failure
NCT00108251 ·Status: COMPLETED ·Phase: PHASE4
-
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
NCT01893788 ·Status: UNKNOWN ·Phase: PHASE4
-
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
NCT01302899 ·Status: TERMINATED ·Phase: PHASE2
-
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
NCT07259512 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
NCT01092130 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA